ASPEN 2024 Nutrition Nutrition Science and Practice Conference

The ASPEN 2024 Nutrition Science & Practice Conference was the premier annual gathering of the American Society for Parenteral and Enteral Nutrition. Held in Tampa, Florida, the 2024 meeting focused on the intersection of cutting-edge science and daily bedside practice, with a particular emphasis on “Mission Nutrition”—redefining the human health span through optimal metabolic support.

The conference addressed the post-pandemic reality of nutrition care, featuring major sessions on supply chain resilience, the integration of Artificial Intelligence (AI) in clinical nutrition, and the release of updated consensus statements for neonatal care.

 What You Will Learn

The curriculum focused on evidence-based updates across the lifespan. Key learning outcomes included:

• Neonatal Updates: A deep dive into the 2024 Preterm Nutrition Consensus Statements, offering new protocols for lipid injectable emulsions (ILE) and aggressive early amino acid dosing for VLBW infants.

• Parenteral Safety: Addressing the controversy of “Can Food Cause Harm?” in a keynote that explored the metabolic risks of parenteral nutrition (PN) overfeeding and liver dysfunction.

• The “GLP” Era: Managing the nutritional implications of GLP-1 agonists (like Semaglutide) in hospitalized patients, specifically regarding delayed gastric emptying and aspiration risk during anesthesia or enteral feeding.

• Microbiome & Metabolism: New insights from the Dudrick Research Symposium on how diet influences host physiology via the gut microbiome.

 Event Details

• Event: ASPEN 2024 Nutrition Science & Practice Conference

• Dates: March 2–5, 2024

• Location: Tampa Convention Center, Tampa, Florida, USA

 Who Should Attend

• Clinical Dietitians (RD/RDN): Particularly those specializing in CNSC certification or critical care.

• Pharmacists: Managing sterile compounding compliance (USP ) and PN shortages.

• Neonatologists & Pediatricians: Who needed the updated 2024 dosing guidelines for preterm infants.

• Nurses: Managing vascular access devices and enteral tubes.

 Why Attend (or Review)

• The Rhoads Lecture: The 2024 Rhoads Research Lecture, titled “Mission Nutrition: Redefining the Human Health Span,” challenged attendees to look beyond “saving lives” in the ICU to “optimizing longevity” and functional recovery.

• Compounding Standards: The President’s Address, “Parenteral Nutrition Compounding: Advancement or Regression?”, was a critical session for pharmacy directors, addressing the regulatory burdens that are currently threatening patient access to custom PN.

• AI in Nutrition: A dedicated track on “Clinical Applications of AI and Machine Learning” demonstrated how new algorithms are predicting malnutrition risk and automating PN calculations.

 Topics

The agenda was divided into specialized tracks:

• Pediatrics & Neonatal:

  • Lipid Injectable Emulsions: Dosing strategies (1–3 g/kg/day) and photoprotection requirements.

  • Metabolic Bone Disease: Screening protocols using Alkaline Phosphatase (ALP) and phosphorus.

• Critical Care:

  • Gastric Residuals: The debate on whether to check them at all (the shift toward “volume-based feeding”).

  • ECMO Nutrition: How to feed the patient on Extracorporeal Membrane Oxygenation without causing gut ischemia.

• Gastroenterology:

  • Intestinal Failure: “Enterally Autonomous, But Not Cured”—managing the long-term micronutrient deficiencies in patients weaned off PN.

  • Pancreatitis: Moving from “bowel rest” to early enteral nutrition.

• Professional Development:

  • Ethics: “Healing or Harming”—navigating the ethical dilemmas of artificial hydration/nutrition at the end of life.